Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Health Catalyst’s Role in Healthcare Analytics in APAC

The future of the healthcare industry is increasingly being shaped by data and analytics. That’s why, for this episode of Owning the Future of Healthcare by Health Catalyst, host Daniel Litwin was joined by Farhana Nakhooda, Health Catalyst Senior Vice President of Healthcare and Life Sciences for APAC, who shared her influential insights. In particular,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Health Catalyst’s Role in Healthcare Analytics in APAC

The future of the healthcare industry is increasingly being shaped by data and analytics. That’s why, for this episode of Owning the Future of Healthcare by Health Catalyst, host Daniel Litwin was joined by Farhana Nakhooda, Health Catalyst Senior Vice President of Healthcare and Life Sciences for APAC, who shared her influential insights.

In particular, Nakhooda contributed to an in-depth discussion about the organization’s impact on the efficient and equitable use of data and analytics in the Asia-Pacific region, or APAC.

Because the region is so large, Nakhooda said it’s impossible to generalize about universal trends in the area. However, when viewed through the lens of developed and developing markets, some easier-to-identify groupings and trends emerge.

While developed markets are more prepared for analytics than their developing counterparts thanks to, in many cases, years of EMR use, that doesn’t mean the adoption of more robust analytics will be simple. For example, digitization varies greatly among even developed markets, which can lead to implementation challenges.

Among developing markets, work is still centralized around enabling data capture in the first place.

Even though these segments of the region are at different stages of preparedness and adoption, Nakhooda said they do have some things in common, such as a requirement to share data with their governments.

Health Catalyst is working to help the region increase understanding of data security and the structure around data sharing and governance, as well as to help increase data and analytics literacy in the region, which is shining a spotlight on the power of data in improving outcomes and more.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Rebuilding Medicine Around Presence: The Future of Physician House Calls with Dr. Yevhen Pavelko, Founder of Inviah Health

Dr. Yevhen Pavelko, founder of Inviah Health, is advocating for the resurgence of physician house calls. He believes that personal interaction can significantly improve patient care and satisfaction. Inviah Health aims to modernize this traditional approach by integrating advanced medical technology.

  • 01Dr. Yevhen Pavelko supports the revival of physician house calls to improve patient care.
  • 02Inviah Health focuses on integrating advanced technology with traditional house call practices.
  • 03Personal interaction between doctors and patients can enhance care and satisfaction.

Jul 31, 2026

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512